EXIT

Main information

  • Trade name:
  • EXIT 1 TAB
  • Dosage:
  • 100,150;MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 1
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXIT 1 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

15-11-2017

PROHIBIT (Levamisole Hydrochloride) Solution [Agri Laboratories, Ltd.]

PROHIBIT (Levamisole Hydrochloride) Solution [Agri Laboratories, Ltd.]

Updated Date: Nov 15, 2017 EST

US - DailyMed

22-9-2017

EMVERM (Mebendazole) Tablet, Chewable [Amedra Pharmaceuticals LLC]

EMVERM (Mebendazole) Tablet, Chewable [Amedra Pharmaceuticals LLC]

Updated Date: Sep 22, 2017 EST

US - DailyMed

22-9-2017

EMVERM (Mebendazole) Tablet, Chewable [Impax Specialty Pharma]

EMVERM (Mebendazole) Tablet, Chewable [Impax Specialty Pharma]

Updated Date: Sep 22, 2017 EST

US - DailyMed

17-8-2017

AX PHARMACEUTICAL CORP (Levamisole Hydrochloride) Powder [AX Pharmaceutical Corp]

AX PHARMACEUTICAL CORP (Levamisole Hydrochloride) Powder [AX Pharmaceutical Corp]

Updated Date: Aug 17, 2017 EST

US - DailyMed

23-6-2017

Withdrawn application:  Elmisol, levamisole, Initial authorisation

Withdrawn application: Elmisol, levamisole, Initial authorisation

Europe - EMA - European Medicines Agency